The Patent Finder

Ferrer Internacional, S.A.

Also on record
Records under this name other than the patents Ferrer Internacional, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Back to Ferrer Internacional, S.A.

PatentTitleStatus Expires Confidence
US 8,545,816Benzoic acid ester compounds, compositions, uses and methods related thereto
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,753,680Capsule for the prevention of cardiovascular diseases
Lapsed on the fee record
Ended Jun 17, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 17, 2026From the USPTO record
US 8,507,6841-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts
Lapsed on the fee record
Ended Aug 13, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 13, 2025From the USPTO record
US 7,635,691Use of CDP-choline for the prophylactic treatment of cerebral ischemia
Term ended
Term ended Nov 9, 2023 · From the USPTO record
Term endedTerm ended Nov 9, 2023From the USPTO record
US 8,039,476Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
Lapsed on the fee record
Ended Oct 18, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 18, 2023From the USPTO record
US 8,008,486Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
Lapsed on the fee record
Ended Aug 30, 2023 · From the USPTO record
Lapsed on the fee recordEnded Aug 30, 2023From the USPTO record
US 10,072,000Method of treating insomnia with halogenated pyrazolo[1,5-a]pyrimidines
Lapsed on the fee record
Ended Sep 11, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 11, 2022From the USPTO record
US 8,530,482Halogenated pyrazolo[1,5-A]pyrimidines, processes, uses, compositions and intermediates
Lapsed on the fee record
Ended Sep 10, 2021 · From the USPTO record
Lapsed on the fee recordEnded Sep 10, 2021From the USPTO record
US 6,894,032Use of CDP-choline for the treatment of alcohol withdrawal syndrome
Formerly held
Term ended
Term ended Jul 28, 2021 · From the USPTO record
Term endedTerm ended Jul 28, 2021From the USPTO record
US 6,930,096Use of CDP-choline for the prophylactic treatment of cerebral ischemia
Formerly held
Term ended
Term ended Apr 22, 2021 · From the USPTO record
Term endedTerm ended Apr 22, 2021From the USPTO record
10 of 52 patents shown.
Pro members see all 52.
Pro members: see all 52 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited